

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | vocalization behavior (GO:0071625) | 5.47091509 |
| 2 | cornea development in camera-type eye (GO:0061303) | 5.33576119 |
| 3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.25391911 |
| 4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.17119667 |
| 5 | neuron cell-cell adhesion (GO:0007158) | 5.08679161 |
| 6 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.92433193 |
| 7 | presynaptic membrane assembly (GO:0097105) | 4.91231544 |
| 8 | synaptic vesicle exocytosis (GO:0016079) | 4.87417054 |
| 9 | glutamate secretion (GO:0014047) | 4.86203513 |
| 10 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.83719963 |
| 11 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.83388329 |
| 12 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.71548406 |
| 13 | glutamate receptor signaling pathway (GO:0007215) | 4.63418175 |
| 14 | neuronal action potential propagation (GO:0019227) | 4.59547858 |
| 15 | protein localization to synapse (GO:0035418) | 4.56364860 |
| 16 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.54299733 |
| 17 | presynaptic membrane organization (GO:0097090) | 4.54134360 |
| 18 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.53576273 |
| 19 | neuron-neuron synaptic transmission (GO:0007270) | 4.45744836 |
| 20 | synaptic transmission, glutamatergic (GO:0035249) | 4.41107557 |
| 21 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.34131287 |
| 22 | activated T cell proliferation (GO:0050798) | 4.23465313 |
| 23 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.23083810 |
| 24 | locomotory exploration behavior (GO:0035641) | 4.18591869 |
| 25 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.13261715 |
| 26 | neurotransmitter secretion (GO:0007269) | 4.13095357 |
| 27 | synaptic vesicle maturation (GO:0016188) | 4.04405322 |
| 28 | proline transport (GO:0015824) | 4.03895359 |
| 29 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.98993864 |
| 30 | regulation of synaptic vesicle transport (GO:1902803) | 3.96810151 |
| 31 | neural tube formation (GO:0001841) | 3.94310260 |
| 32 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.92243721 |
| 33 | gamma-aminobutyric acid transport (GO:0015812) | 3.87191698 |
| 34 | postsynaptic membrane organization (GO:0001941) | 3.84542250 |
| 35 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.83523653 |
| 36 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.77934989 |
| 37 | long-term synaptic potentiation (GO:0060291) | 3.75737756 |
| 38 | startle response (GO:0001964) | 3.75560799 |
| 39 | response to histamine (GO:0034776) | 3.73092688 |
| 40 | regulation of postsynaptic membrane potential (GO:0060078) | 3.69033487 |
| 41 | positive regulation of synapse maturation (GO:0090129) | 3.68882574 |
| 42 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.66475277 |
| 43 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.66198739 |
| 44 | cerebellar granule cell differentiation (GO:0021707) | 3.65080047 |
| 45 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.64848260 |
| 46 | regulation of timing of cell differentiation (GO:0048505) | 3.63322803 |
| 47 | neurotransmitter transport (GO:0006836) | 3.60621543 |
| 48 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.53981288 |
| 49 | behavioral defense response (GO:0002209) | 3.53304815 |
| 50 | behavioral fear response (GO:0001662) | 3.53304815 |
| 51 | negative regulation of cell killing (GO:0031342) | 3.52676315 |
| 52 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.52676315 |
| 53 | neuron recognition (GO:0008038) | 3.51093302 |
| 54 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.48615781 |
| 55 | exploration behavior (GO:0035640) | 3.48076527 |
| 56 | transmission of nerve impulse (GO:0019226) | 3.45517230 |
| 57 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.39712592 |
| 58 | positive regulation of membrane potential (GO:0045838) | 3.39273363 |
| 59 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.39161039 |
| 60 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.37771044 |
| 61 | long-term memory (GO:0007616) | 3.37451454 |
| 62 | fear response (GO:0042596) | 3.34969293 |
| 63 | synaptic vesicle endocytosis (GO:0048488) | 3.33389201 |
| 64 | regulation of synaptic plasticity (GO:0048167) | 3.31315520 |
| 65 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.30134282 |
| 66 | astrocyte differentiation (GO:0048708) | 3.29266880 |
| 67 | microglial cell activation (GO:0001774) | 3.28581217 |
| 68 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.26998494 |
| 69 | establishment of protein localization to Golgi (GO:0072600) | 3.26158357 |
| 70 | regulation of neurotransmitter levels (GO:0001505) | 3.23375590 |
| 71 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.20144282 |
| 72 | synapse assembly (GO:0007416) | 3.19186821 |
| 73 | striatum development (GO:0021756) | 3.17366762 |
| 74 | regulation of development, heterochronic (GO:0040034) | 3.14775804 |
| 75 | membrane depolarization (GO:0051899) | 3.10555494 |
| 76 | neutrophil mediated immunity (GO:0002446) | 3.10143116 |
| 77 | regulation of synapse maturation (GO:0090128) | 3.10077507 |
| 78 | detection of molecule of bacterial origin (GO:0032490) | 3.08222171 |
| 79 | dendritic spine morphogenesis (GO:0060997) | 3.08113834 |
| 80 | regulation of neurotransmitter secretion (GO:0046928) | 3.07870703 |
| 81 | protein targeting to Golgi (GO:0000042) | 3.07618098 |
| 82 | positive regulation by symbiont of host defense response (GO:0052509) | 3.07546888 |
| 83 | modulation by symbiont of host defense response (GO:0052031) | 3.07546888 |
| 84 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.07546888 |
| 85 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.07546888 |
| 86 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.07546888 |
| 87 | modulation by symbiont of host immune response (GO:0052553) | 3.07546888 |
| 88 | long term synaptic depression (GO:0060292) | 3.06376098 |
| 89 | synaptic transmission (GO:0007268) | 3.06162436 |
| 90 | righting reflex (GO:0060013) | 3.04435420 |
| 91 | regulation of vesicle fusion (GO:0031338) | 3.03543091 |
| 92 | intraspecies interaction between organisms (GO:0051703) | 3.01760085 |
| 93 | social behavior (GO:0035176) | 3.01760085 |
| 94 | behavioral response to cocaine (GO:0048148) | 3.01167236 |
| 95 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.00864240 |
| 96 | positive regulation of muscle hypertrophy (GO:0014742) | 3.00766440 |
| 97 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 3.00766440 |
| 98 | positive regulation of cell fate commitment (GO:0010455) | 3.00443231 |
| 99 | interferon-gamma production (GO:0032609) | 2.98925438 |
| 100 | myeloid leukocyte mediated immunity (GO:0002444) | 2.97347741 |
| 101 | negative regulation of dendrite development (GO:2000171) | 2.96641791 |
| 102 | learning (GO:0007612) | 2.96099495 |
| 103 | positive regulation of synapse assembly (GO:0051965) | 2.95092655 |
| 104 | cellular response to interleukin-15 (GO:0071350) | 2.94942913 |
| 105 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.94354067 |
| 106 | regulation of glutamate secretion (GO:0014048) | 2.93597379 |
| 107 | membrane hyperpolarization (GO:0060081) | 2.92160099 |
| 108 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.91942008 |
| 109 | positive regulation of synaptic transmission (GO:0050806) | 2.91642358 |
| 110 | regulation of germinal center formation (GO:0002634) | 2.90078981 |
| 111 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.89570486 |
| 112 | axonal fasciculation (GO:0007413) | 2.88859135 |
| 113 | protein localization to cilium (GO:0061512) | 2.88009308 |
| 114 | auditory behavior (GO:0031223) | 2.87643594 |
| 115 | negative regulation of T cell mediated immunity (GO:0002710) | 2.87245749 |
| 116 | membrane depolarization during action potential (GO:0086010) | 2.86967732 |
| 117 | positive regulation of interferon-alpha production (GO:0032727) | 2.86844279 |
| 118 | mechanosensory behavior (GO:0007638) | 2.86016121 |
| 119 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.85012627 |
| 120 | detection of calcium ion (GO:0005513) | 2.84796580 |
| 121 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.84577570 |
| 122 | regulation of synaptic transmission (GO:0050804) | 2.83815748 |
| 123 | rRNA methylation (GO:0031167) | 2.82284973 |
| 124 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.82029605 |
| 125 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.82018386 |
| 126 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.82012475 |
| 127 | regulation of cell communication by electrical coupling (GO:0010649) | 2.81597716 |
| 128 | female mating behavior (GO:0060180) | 2.80666236 |
| 129 | regulation of neurotransmitter transport (GO:0051588) | 2.79195758 |
| 130 | negative regulation of sodium ion transport (GO:0010766) | 2.79153243 |
| 131 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.78567869 |
| 132 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.77905100 |
| 133 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.77565727 |
| 134 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.76875308 |
| 135 | response to interleukin-15 (GO:0070672) | 2.75706526 |
| 136 | cellular potassium ion homeostasis (GO:0030007) | 2.75699876 |
| 137 | regulation of female receptivity (GO:0045924) | 2.75481922 |
| 138 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.75368180 |
| 139 | regulation of dendritic spine development (GO:0060998) | 2.75157207 |
| 140 | regulation of interferon-alpha production (GO:0032647) | 2.68364511 |
| 141 | macrophage activation involved in immune response (GO:0002281) | 2.67596915 |
| 142 | behavioral response to nicotine (GO:0035095) | 2.67020648 |
| 143 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.65300260 |
| 144 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.65300260 |
| 145 | negative regulation of neurotransmitter transport (GO:0051589) | 2.65152332 |
| 146 | positive T cell selection (GO:0043368) | 2.64349567 |
| 147 | regulation of memory T cell differentiation (GO:0043380) | 2.61645453 |
| 148 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.57022900 |
| 149 | negative regulation of B cell mediated immunity (GO:0002713) | 2.57022900 |
| 150 | regulation of gamma-delta T cell activation (GO:0046643) | 2.56577677 |
| 151 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.56384750 |
| 152 | histone H3-K9 methylation (GO:0051567) | 2.54257531 |
| 153 | negative T cell selection (GO:0043383) | 2.53468663 |
| 154 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.52922064 |
| 155 | DNA deamination (GO:0045006) | 2.52900616 |
| 156 | negative regulation of adaptive immune response (GO:0002820) | 2.52304772 |
| 157 | hindbrain development (GO:0030902) | 2.49619753 |
| 158 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.49452725 |
| 159 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.48266000 |
| 160 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.47790358 |
| 161 | positive regulation of defense response to virus by host (GO:0002230) | 2.46806508 |
| 162 | adaptation of signaling pathway (GO:0023058) | 2.45275309 |
| 163 | cellular extravasation (GO:0045123) | 2.44802276 |
| 164 | histone H3-K9 modification (GO:0061647) | 2.41440707 |
| 165 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.40708001 |
| 166 | macrophage activation (GO:0042116) | 2.40694591 |
| 167 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.39458275 |
| 168 | neutrophil activation (GO:0042119) | 2.39209431 |
| 169 | protein localization to Golgi apparatus (GO:0034067) | 2.38230989 |
| 170 | peptidyl-lysine trimethylation (GO:0018023) | 2.37098048 |
| 171 | negative regulation of B cell proliferation (GO:0030889) | 2.37050858 |
| 172 | negative regulation of mast cell activation (GO:0033004) | 2.37018356 |
| 173 | regulation of regulatory T cell differentiation (GO:0045589) | 2.36709066 |
| 174 | gland morphogenesis (GO:0022612) | 2.36168744 |
| 175 | protein K11-linked deubiquitination (GO:0035871) | 2.35707270 |
| 176 | positive regulation of interferon-beta production (GO:0032728) | 2.34955673 |
| 177 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.34896830 |
| 178 | negative thymic T cell selection (GO:0045060) | 2.32518250 |
| 179 | negative regulation of alpha-beta T cell differentiation (GO:0046639) | 2.29485656 |
| 180 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.29280504 |
| 181 | dorsal/ventral axis specification (GO:0009950) | 2.28911292 |
| 182 | RNA destabilization (GO:0050779) | 2.26885744 |
| 183 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.25469330 |
| 184 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.25469330 |
| 185 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.25469330 |
| 186 | photoreceptor cell development (GO:0042461) | 2.22709676 |
| 187 | B cell receptor signaling pathway (GO:0050853) | 2.21166661 |
| 188 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.21147046 |
| 189 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.18889929 |
| 190 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.17717383 |
| 191 | positive regulation of mast cell activation (GO:0033005) | 2.17319364 |
| 192 | regulation of mast cell activation (GO:0033003) | 2.17006218 |
| 193 | detection of external biotic stimulus (GO:0098581) | 2.16873509 |
| 194 | positive regulation of granulocyte differentiation (GO:0030854) | 2.16813807 |
| 195 | sulfation (GO:0051923) | 2.15668236 |
| 196 | glandular epithelial cell differentiation (GO:0002067) | 2.15089286 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.29239618 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.47026179 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.82529903 |
| 4 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.81126428 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.75682534 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.61646930 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.36807532 |
| 8 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.33132960 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.31657945 |
| 10 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.30213015 |
| 11 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.29654543 |
| 12 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.27409136 |
| 13 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.27409136 |
| 14 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.25328300 |
| 15 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.23716157 |
| 16 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.21055983 |
| 17 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.14479380 |
| 18 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.13504567 |
| 19 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.12459018 |
| 20 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.11450557 |
| 21 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.11358955 |
| 22 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.10578428 |
| 23 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.10144586 |
| 24 | SMAD4_21799915_ChIP-Seq_A2780_Human | 2.07504159 |
| 25 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.06857468 |
| 26 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.06382459 |
| 27 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.04097374 |
| 28 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.01172908 |
| 29 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.96454758 |
| 30 | P300_19829295_ChIP-Seq_ESCs_Human | 1.92026387 |
| 31 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.91018100 |
| 32 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.86677684 |
| 33 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.86254718 |
| 34 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.83401583 |
| 35 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.81624322 |
| 36 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.78073710 |
| 37 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.77161801 |
| 38 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.69685035 |
| 39 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.69146724 |
| 40 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.68967932 |
| 41 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.68092637 |
| 42 | FUS_26573619_Chip-Seq_HEK293_Human | 1.67376530 |
| 43 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.64761876 |
| 44 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.63394671 |
| 45 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.62889590 |
| 46 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.61536332 |
| 47 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.61009565 |
| 48 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.59921831 |
| 49 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.59867719 |
| 50 | * FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.58616957 |
| 51 | VDR_22108803_ChIP-Seq_LS180_Human | 1.57507683 |
| 52 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.55338649 |
| 53 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.50829500 |
| 54 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.50016635 |
| 55 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.49721862 |
| 56 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.47678088 |
| 57 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.47639763 |
| 58 | AR_25329375_ChIP-Seq_VCAP_Human | 1.47560639 |
| 59 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.45849236 |
| 60 | EWS_26573619_Chip-Seq_HEK293_Human | 1.44032918 |
| 61 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.43907813 |
| 62 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.41238933 |
| 63 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.40799045 |
| 64 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.39565374 |
| 65 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.39520275 |
| 66 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.38103994 |
| 67 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.37611099 |
| 68 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.37336282 |
| 69 | * PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.36998956 |
| 70 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.36694828 |
| 71 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.36694828 |
| 72 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.36242698 |
| 73 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.36068565 |
| 74 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.35774149 |
| 75 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.35482147 |
| 76 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.32671386 |
| 77 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.32142274 |
| 78 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.31188255 |
| 79 | TCF4_23295773_ChIP-Seq_U87_Human | 1.31069709 |
| 80 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.26827947 |
| 81 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.25741010 |
| 82 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.25570988 |
| 83 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.24416934 |
| 84 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.23910789 |
| 85 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.23815664 |
| 86 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.23139636 |
| 87 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.22570781 |
| 88 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.22499425 |
| 89 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.21655827 |
| 90 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.21602722 |
| 91 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.21518426 |
| 92 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.21502808 |
| 93 | TP53_16413492_ChIP-PET_HCT116_Human | 1.19899494 |
| 94 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.19713560 |
| 95 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.19563398 |
| 96 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.19155804 |
| 97 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.17045413 |
| 98 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.15381434 |
| 99 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.15021369 |
| 100 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.14788381 |
| 101 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.14691054 |
| 102 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.14336564 |
| 103 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.14165058 |
| 104 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.13851865 |
| 105 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.12897287 |
| 106 | JUN_21703547_ChIP-Seq_K562_Human | 1.12773098 |
| 107 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.11710826 |
| 108 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.11633514 |
| 109 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.10496954 |
| 110 | AR_19668381_ChIP-Seq_PC3_Human | 1.08810713 |
| 111 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.08227734 |
| 112 | RXR_22108803_ChIP-Seq_LS180_Human | 1.07565824 |
| 113 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.07321200 |
| 114 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.06965671 |
| 115 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.06760768 |
| 116 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.06251596 |
| 117 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.05688309 |
| 118 | GATA3_26560356_Chip-Seq_TH2_Human | 1.05619114 |
| 119 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.04969326 |
| 120 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.04616481 |
| 121 | * EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.04586488 |
| 122 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.04200218 |
| 123 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.03652380 |
| 124 | * PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.02707176 |
| 125 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.02599525 |
| 126 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02599525 |
| 127 | * P300_18555785_Chip-Seq_ESCs_Mouse | 1.02438478 |
| 128 | * SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.02396588 |
| 129 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.01603079 |
| 130 | KDM2B_26808549_Chip-Seq_REH_Human | 1.01300283 |
| 131 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.01112745 |
| 132 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.00276760 |
| 133 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.00063696 |
| 134 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.99533730 |
| 135 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.99469604 |
| 136 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99330700 |
| 137 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.98570678 |
| 138 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.98570678 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 5.21825900 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 5.03586006 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.76206746 |
| 4 | MP0000569_abnormal_digit_pigmentation | 3.57033006 |
| 5 | MP0003724_increased_susceptibility_to | 3.43027615 |
| 6 | MP0009745_abnormal_behavioral_response | 3.40382861 |
| 7 | MP0009046_muscle_twitch | 3.32594229 |
| 8 | MP0002064_seizures | 3.10714703 |
| 9 | MP0002063_abnormal_learning/memory/cond | 3.08229966 |
| 10 | MP0001968_abnormal_touch/_nociception | 3.05266479 |
| 11 | MP0004270_analgesia | 3.04502123 |
| 12 | MP0002572_abnormal_emotion/affect_behav | 2.84994717 |
| 13 | MP0001501_abnormal_sleep_pattern | 2.75583437 |
| 14 | MP0002272_abnormal_nervous_system | 2.70001778 |
| 15 | MP0002822_catalepsy | 2.62055513 |
| 16 | MP0002735_abnormal_chemical_nociception | 2.57220560 |
| 17 | MP0001486_abnormal_startle_reflex | 2.55702855 |
| 18 | MP0002736_abnormal_nociception_after | 2.53657833 |
| 19 | MP0002734_abnormal_mechanical_nocicepti | 2.44791316 |
| 20 | MP0001440_abnormal_grooming_behavior | 2.22704580 |
| 21 | MP0002876_abnormal_thyroid_physiology | 2.19231146 |
| 22 | MP0002067_abnormal_sensory_capabilities | 2.16572005 |
| 23 | MP0001188_hyperpigmentation | 2.13768822 |
| 24 | MP0005423_abnormal_somatic_nervous | 2.05195067 |
| 25 | MP0006276_abnormal_autonomic_nervous | 2.01403996 |
| 26 | MP0008789_abnormal_olfactory_epithelium | 2.00880275 |
| 27 | MP0005646_abnormal_pituitary_gland | 1.99566827 |
| 28 | MP0001984_abnormal_olfaction | 1.92133771 |
| 29 | MP0008057_abnormal_DNA_replication | 1.87084997 |
| 30 | MP0005386_behavior/neurological_phenoty | 1.81125467 |
| 31 | MP0004924_abnormal_behavior | 1.81125467 |
| 32 | MP0002733_abnormal_thermal_nociception | 1.81082327 |
| 33 | MP0001970_abnormal_pain_threshold | 1.77410835 |
| 34 | MP0005671_abnormal_response_to | 1.76373325 |
| 35 | MP0002102_abnormal_ear_morphology | 1.75471931 |
| 36 | MP0003787_abnormal_imprinting | 1.69562903 |
| 37 | MP0005257_abnormal_intraocular_pressure | 1.68279645 |
| 38 | MP0001835_abnormal_antigen_presentation | 1.67728003 |
| 39 | MP0002184_abnormal_innervation | 1.64252509 |
| 40 | MP0005551_abnormal_eye_electrophysiolog | 1.56716190 |
| 41 | MP0001800_abnormal_humoral_immune | 1.56164024 |
| 42 | MP0002557_abnormal_social/conspecific_i | 1.54326330 |
| 43 | MP0000778_abnormal_nervous_system | 1.53618908 |
| 44 | MP0003121_genomic_imprinting | 1.53037560 |
| 45 | MP0003879_abnormal_hair_cell | 1.52037024 |
| 46 | MP0004142_abnormal_muscle_tone | 1.47985589 |
| 47 | MP0002837_dystrophic_cardiac_calcinosis | 1.46938584 |
| 48 | MP0009780_abnormal_chondrocyte_physiolo | 1.46528389 |
| 49 | MP0001919_abnormal_reproductive_system | 1.45949714 |
| 50 | MP0005645_abnormal_hypothalamus_physiol | 1.44951261 |
| 51 | MP0008569_lethality_at_weaning | 1.44860024 |
| 52 | MP0006292_abnormal_olfactory_placode | 1.43888975 |
| 53 | MP0001529_abnormal_vocalization | 1.43751072 |
| 54 | MP0002160_abnormal_reproductive_system | 1.36086619 |
| 55 | MP0003195_calcinosis | 1.35574067 |
| 56 | MP0008872_abnormal_physiological_respon | 1.31963593 |
| 57 | MP0002909_abnormal_adrenal_gland | 1.30283084 |
| 58 | MP0004858_abnormal_nervous_system | 1.27882610 |
| 59 | MP0002066_abnormal_motor_capabilities/c | 1.26447728 |
| 60 | MP0005389_reproductive_system_phenotype | 1.24527561 |
| 61 | MP0001905_abnormal_dopamine_level | 1.23855504 |
| 62 | MP0010386_abnormal_urinary_bladder | 1.23821253 |
| 63 | MP0000955_abnormal_spinal_cord | 1.21479825 |
| 64 | MP0003329_amyloid_beta_deposits | 1.21261379 |
| 65 | MP0002882_abnormal_neuron_morphology | 1.21235506 |
| 66 | MP0002723_abnormal_immune_serum | 1.20511626 |
| 67 | MP0003633_abnormal_nervous_system | 1.20126774 |
| 68 | MP0003646_muscle_fatigue | 1.19197479 |
| 69 | MP0001502_abnormal_circadian_rhythm | 1.18612704 |
| 70 | MP0005535_abnormal_body_temperature | 1.18563485 |
| 71 | MP0004811_abnormal_neuron_physiology | 1.15789201 |
| 72 | MP0002277_abnormal_respiratory_mucosa | 1.15244045 |
| 73 | MP0002420_abnormal_adaptive_immunity | 1.13885153 |
| 74 | MP0002928_abnormal_bile_duct | 1.11866468 |
| 75 | MP0008875_abnormal_xenobiotic_pharmacok | 1.11805382 |
| 76 | MP0000613_abnormal_salivary_gland | 1.11744242 |
| 77 | MP0001819_abnormal_immune_cell | 1.11472236 |
| 78 | MP0005174_abnormal_tail_pigmentation | 1.10540281 |
| 79 | MP0005000_abnormal_immune_tolerance | 1.08921046 |
| 80 | MP0009785_altered_susceptibility_to | 1.08698951 |
| 81 | MP0005310_abnormal_salivary_gland | 1.06956967 |
| 82 | MP0003122_maternal_imprinting | 1.06589540 |
| 83 | MP0002638_abnormal_pupillary_reflex | 1.05432382 |
| 84 | MP0002229_neurodegeneration | 1.04635014 |
| 85 | MP0002452_abnormal_antigen_presenting | 1.03649974 |
| 86 | MP0001485_abnormal_pinna_reflex | 1.02705687 |
| 87 | MP0001177_atelectasis | 1.01358328 |
| 88 | MP0001963_abnormal_hearing_physiology | 1.01149714 |
| 89 | MP0005025_abnormal_response_to | 1.00562396 |
| 90 | MP0003631_nervous_system_phenotype | 0.99505687 |
| 91 | MP0004885_abnormal_endolymph | 0.99007665 |
| 92 | MP0004742_abnormal_vestibular_system | 0.98952149 |
| 93 | MP0002419_abnormal_innate_immunity | 0.98442090 |
| 94 | MP0000383_abnormal_hair_follicle | 0.98340887 |
| 95 | MP0005394_taste/olfaction_phenotype | 0.96315851 |
| 96 | MP0005499_abnormal_olfactory_system | 0.96315851 |
| 97 | MP0001790_abnormal_immune_system | 0.95325400 |
| 98 | MP0005387_immune_system_phenotype | 0.95325400 |
| 99 | MP0000013_abnormal_adipose_tissue | 0.94660022 |
| 100 | MP0008874_decreased_physiological_sensi | 0.94596765 |
| 101 | MP0000685_abnormal_immune_system | 0.94366152 |
| 102 | MP0000427_abnormal_hair_cycle | 0.94202979 |
| 103 | MP0002693_abnormal_pancreas_physiology | 0.92803553 |
| 104 | MP0002938_white_spotting | 0.91986477 |
| 105 | MP0004043_abnormal_pH_regulation | 0.91618266 |
| 106 | MP0000465_gastrointestinal_hemorrhage | 0.91298282 |
| 107 | MP0003763_abnormal_thymus_physiology | 0.91222344 |
| 108 | MP0004381_abnormal_hair_follicle | 0.89925583 |
| 109 | MP0009764_decreased_sensitivity_to | 0.88183818 |
| 110 | MP0003252_abnormal_bile_duct | 0.87985083 |
| 111 | MP0002332_abnormal_exercise_endurance | 0.87056706 |
| 112 | MP0002405_respiratory_system_inflammati | 0.86608167 |
| 113 | MP0002752_abnormal_somatic_nervous | 0.85742334 |
| 114 | MP0005379_endocrine/exocrine_gland_phen | 0.85608128 |
| 115 | MP0008995_early_reproductive_senescence | 0.85482019 |
| 116 | MP0002069_abnormal_eating/drinking_beha | 0.85382624 |
| 117 | MP0000631_abnormal_neuroendocrine_gland | 0.84768001 |
| 118 | MP0003303_peritoneal_inflammation | 0.84312084 |
| 119 | MP0002152_abnormal_brain_morphology | 0.84283780 |
| 120 | MP0000716_abnormal_immune_system | 0.83128244 |
| 121 | MP0000015_abnormal_ear_pigmentation | 0.81388266 |
| 122 | MP0003866_abnormal_defecation | 0.80477569 |
| 123 | MP0003436_decreased_susceptibility_to | 0.80042489 |
| 124 | MP0002398_abnormal_bone_marrow | 0.77639855 |
| 125 | MP0004484_altered_response_of | 0.77167383 |
| 126 | MP0006035_abnormal_mitochondrial_morpho | 0.76895684 |
| 127 | MP0005084_abnormal_gallbladder_morpholo | 0.76341435 |
| 128 | MP0004085_abnormal_heartbeat | 0.76321260 |
| 129 | MP0010678_abnormal_skin_adnexa | 0.75860641 |
| 130 | MP0002090_abnormal_vision | 0.73915791 |
| 131 | MP0008877_abnormal_DNA_methylation | 0.73340737 |
| 132 | MP0002138_abnormal_hepatobiliary_system | 0.73176607 |
| 133 | MP0003183_abnormal_peptide_metabolism | 0.72908521 |
| 134 | MP0004215_abnormal_myocardial_fiber | 0.72873002 |
| 135 | MP0000689_abnormal_spleen_morphology | 0.71995538 |
| 136 | MP0005670_abnormal_white_adipose | 0.69622923 |
| 137 | MP0005171_absent_coat_pigmentation | 0.67655740 |
| 138 | MP0005253_abnormal_eye_physiology | 0.67370594 |
| 139 | MP0003632_abnormal_nervous_system | 0.65695029 |
| 140 | MP0005409_darkened_coat_color | 0.64335007 |
| 141 | MP0000026_abnormal_inner_ear | 0.62110582 |
| 142 | MP0001986_abnormal_taste_sensitivity | 0.61500513 |
| 143 | MP0004145_abnormal_muscle_electrophysio | 0.61308047 |
| 144 | MP0002254_reproductive_system_inflammat | 0.58411090 |
| 145 | MP0001664_abnormal_digestion | 0.55219792 |
| 146 | MP0006072_abnormal_retinal_apoptosis | 0.55167210 |
| 147 | MP0003690_abnormal_glial_cell | 0.54943757 |
| 148 | MP0003011_delayed_dark_adaptation | 0.53129148 |
| 149 | MP0004130_abnormal_muscle_cell | 0.51650589 |
| 150 | MP0000230_abnormal_systemic_arterial | 0.51308134 |
| 151 | MP0005448_abnormal_energy_balance | 0.51211512 |
| 152 | MP0010234_abnormal_vibrissa_follicle | 0.47375661 |
| 153 | MP0002078_abnormal_glucose_homeostasis | 0.47368825 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 9.08243968 |
| 2 | Febrile seizures (HP:0002373) | 6.45617540 |
| 3 | Hyperventilation (HP:0002883) | 6.19074818 |
| 4 | Epileptic encephalopathy (HP:0200134) | 6.07298077 |
| 5 | Atonic seizures (HP:0010819) | 5.84205054 |
| 6 | Focal seizures (HP:0007359) | 5.65822467 |
| 7 | Hypoplasia of the fovea (HP:0007750) | 4.65007898 |
| 8 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 4.65007898 |
| 9 | Absence seizures (HP:0002121) | 4.57112291 |
| 10 | Dialeptic seizures (HP:0011146) | 4.35026005 |
| 11 | Myokymia (HP:0002411) | 4.34465826 |
| 12 | Generalized tonic-clonic seizures (HP:0002069) | 4.16962243 |
| 13 | Abnormality of the fovea (HP:0000493) | 3.86618466 |
| 14 | Broad-based gait (HP:0002136) | 3.80716884 |
| 15 | Visual hallucinations (HP:0002367) | 3.79858143 |
| 16 | Progressive cerebellar ataxia (HP:0002073) | 3.79323404 |
| 17 | Retrobulbar optic neuritis (HP:0100654) | 3.63465880 |
| 18 | Optic neuritis (HP:0100653) | 3.63465880 |
| 19 | Aplasia/Hypoplasia of the macula (HP:0008059) | 3.54242951 |
| 20 | Protruding tongue (HP:0010808) | 3.41766072 |
| 21 | Gaze-evoked nystagmus (HP:0000640) | 3.35852053 |
| 22 | Excessive salivation (HP:0003781) | 3.35368066 |
| 23 | Drooling (HP:0002307) | 3.35368066 |
| 24 | Amblyopia (HP:0000646) | 3.35359791 |
| 25 | Absent speech (HP:0001344) | 3.30448606 |
| 26 | Stomatitis (HP:0010280) | 3.26486517 |
| 27 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 3.23883233 |
| 28 | Poor eye contact (HP:0000817) | 3.22885003 |
| 29 | Inability to walk (HP:0002540) | 3.20335033 |
| 30 | Orchitis (HP:0100796) | 3.04250821 |
| 31 | Generalized hypopigmentation of hair (HP:0011358) | 3.03927194 |
| 32 | Impaired social interactions (HP:0000735) | 3.00478750 |
| 33 | Abnormal social behavior (HP:0012433) | 3.00478750 |
| 34 | Myositis (HP:0100614) | 2.97571601 |
| 35 | Keratoconjunctivitis (HP:0001096) | 2.87328087 |
| 36 | Dysdiadochokinesis (HP:0002075) | 2.84748155 |
| 37 | Status epilepticus (HP:0002133) | 2.84117900 |
| 38 | Keratitis (HP:0000491) | 2.83654475 |
| 39 | Abnormality of the lower motor neuron (HP:0002366) | 2.83034203 |
| 40 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.79490417 |
| 41 | Fair hair (HP:0002286) | 2.78191573 |
| 42 | Pancreatic cysts (HP:0001737) | 2.74964838 |
| 43 | Abnormality of T cell number (HP:0011839) | 2.71957509 |
| 44 | Keratoconjunctivitis sicca (HP:0001097) | 2.69285638 |
| 45 | Volvulus (HP:0002580) | 2.66697111 |
| 46 | Truncal ataxia (HP:0002078) | 2.66196474 |
| 47 | Epileptiform EEG discharges (HP:0011182) | 2.65271084 |
| 48 | Blue irides (HP:0000635) | 2.61112865 |
| 49 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.58027102 |
| 50 | Fetal akinesia sequence (HP:0001989) | 2.56499126 |
| 51 | Difficulty running (HP:0009046) | 2.55237094 |
| 52 | T lymphocytopenia (HP:0005403) | 2.51987476 |
| 53 | Scanning speech (HP:0002168) | 2.51819522 |
| 54 | Optic nerve hypoplasia (HP:0000609) | 2.51548834 |
| 55 | Thyroiditis (HP:0100646) | 2.51405326 |
| 56 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.49302899 |
| 57 | True hermaphroditism (HP:0010459) | 2.48441386 |
| 58 | Dysmetria (HP:0001310) | 2.47674249 |
| 59 | Limb dystonia (HP:0002451) | 2.47474589 |
| 60 | Abnormal eating behavior (HP:0100738) | 2.45307894 |
| 61 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.44461009 |
| 62 | Stomach cancer (HP:0012126) | 2.42894401 |
| 63 | Progressive inability to walk (HP:0002505) | 2.41007438 |
| 64 | Action tremor (HP:0002345) | 2.39972251 |
| 65 | EEG with generalized epileptiform discharges (HP:0011198) | 2.39759003 |
| 66 | Generalized myoclonic seizures (HP:0002123) | 2.38683407 |
| 67 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.35056657 |
| 68 | Gastrointestinal infarctions (HP:0005244) | 2.33726924 |
| 69 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.32549219 |
| 70 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.31752461 |
| 71 | Hemiparesis (HP:0001269) | 2.30120063 |
| 72 | Abnormality of eosinophils (HP:0001879) | 2.29896971 |
| 73 | Recurrent fungal infections (HP:0002841) | 2.27298663 |
| 74 | Abnormality of the renal cortex (HP:0011035) | 2.25078104 |
| 75 | Pancreatic fibrosis (HP:0100732) | 2.23485093 |
| 76 | Encephalitis (HP:0002383) | 2.22946892 |
| 77 | Recurrent bacterial skin infections (HP:0005406) | 2.22919959 |
| 78 | Impaired smooth pursuit (HP:0007772) | 2.21689257 |
| 79 | Hyperthyroidism (HP:0000836) | 2.19178392 |
| 80 | Abnormality of salivation (HP:0100755) | 2.19019763 |
| 81 | Gait imbalance (HP:0002141) | 2.18649654 |
| 82 | Anxiety (HP:0000739) | 2.18538226 |
| 83 | Attenuation of retinal blood vessels (HP:0007843) | 2.17263721 |
| 84 | Horizontal nystagmus (HP:0000666) | 2.17011954 |
| 85 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.16002255 |
| 86 | Optic nerve coloboma (HP:0000588) | 2.14115256 |
| 87 | Abnormal hair whorl (HP:0010721) | 2.13746186 |
| 88 | Hypsarrhythmia (HP:0002521) | 2.13477685 |
| 89 | Eczematoid dermatitis (HP:0000976) | 2.13208245 |
| 90 | Decreased central vision (HP:0007663) | 2.12233448 |
| 91 | Papillary thyroid carcinoma (HP:0002895) | 2.10963554 |
| 92 | Impaired vibratory sensation (HP:0002495) | 2.09468142 |
| 93 | Polyphagia (HP:0002591) | 2.08169921 |
| 94 | Hip dysplasia (HP:0001385) | 2.07887471 |
| 95 | Sensory axonal neuropathy (HP:0003390) | 2.07015511 |
| 96 | Recurrent cutaneous fungal infections (HP:0011370) | 2.06726047 |
| 97 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.06726047 |
| 98 | Supranuclear gaze palsy (HP:0000605) | 2.02463093 |
| 99 | Oligomenorrhea (HP:0000876) | 2.01973854 |
| 100 | Hemiplegia (HP:0002301) | 2.01714134 |
| 101 | Leukocytosis (HP:0001974) | 2.01703872 |
| 102 | Depression (HP:0000716) | 1.99954732 |
| 103 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.99549603 |
| 104 | Bradykinesia (HP:0002067) | 1.99080813 |
| 105 | Abnormality of the corticospinal tract (HP:0002492) | 1.98871241 |
| 106 | Medial flaring of the eyebrow (HP:0010747) | 1.98277411 |
| 107 | Congenital primary aphakia (HP:0007707) | 1.97823550 |
| 108 | Hypochromic anemia (HP:0001931) | 1.97159565 |
| 109 | Hemoptysis (HP:0002105) | 1.96206297 |
| 110 | Abnormality of T cells (HP:0002843) | 1.94821141 |
| 111 | Recurrent abscess formation (HP:0002722) | 1.94738854 |
| 112 | Hypochromic microcytic anemia (HP:0004840) | 1.92933214 |
| 113 | Abnormal ciliary motility (HP:0012262) | 1.92040085 |
| 114 | Mediastinal lymphadenopathy (HP:0100721) | 1.91642243 |
| 115 | Abolished electroretinogram (ERG) (HP:0000550) | 1.90209164 |
| 116 | Postural instability (HP:0002172) | 1.90162719 |
| 117 | Papilledema (HP:0001085) | 1.88662508 |
| 118 | Molar tooth sign on MRI (HP:0002419) | 1.87062055 |
| 119 | Abnormality of midbrain morphology (HP:0002418) | 1.87062055 |
| 120 | Aqueductal stenosis (HP:0002410) | 1.85480040 |
| 121 | Failure to thrive in infancy (HP:0001531) | 1.85156200 |
| 122 | Short 1st metacarpal (HP:0010034) | 1.85074680 |
| 123 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 1.85074680 |
| 124 | Eosinophilia (HP:0001880) | 1.84605357 |
| 125 | Spastic gait (HP:0002064) | 1.84106431 |
| 126 | Nephronophthisis (HP:0000090) | 1.83723443 |
| 127 | Nephrogenic diabetes insipidus (HP:0009806) | 1.82515711 |
| 128 | Exotropia (HP:0000577) | 1.82470476 |
| 129 | Abnormality of the labia minora (HP:0012880) | 1.82133633 |
| 130 | Abnormality of the renal medulla (HP:0100957) | 1.81539592 |
| 131 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.81001286 |
| 132 | Widely spaced teeth (HP:0000687) | 1.80940703 |
| 133 | Intention tremor (HP:0002080) | 1.80540563 |
| 134 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.79685366 |
| 135 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.79685366 |
| 136 | Poor suck (HP:0002033) | 1.78889567 |
| 137 | Chronic hepatic failure (HP:0100626) | 1.78219411 |
| 138 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.78013508 |
| 139 | Absent/shortened dynein arms (HP:0200106) | 1.78013508 |
| 140 | Genetic anticipation (HP:0003743) | 1.77578358 |
| 141 | Intellectual disability, severe (HP:0010864) | 1.76968491 |
| 142 | Severe combined immunodeficiency (HP:0004430) | 1.76540164 |
| 143 | Pheochromocytoma (HP:0002666) | 1.76413468 |
| 144 | Dysmetric saccades (HP:0000641) | 1.76266093 |
| 145 | Gait ataxia (HP:0002066) | 1.76218908 |
| 146 | Vasculitis (HP:0002633) | 1.75658188 |
| 147 | Congenital stationary night blindness (HP:0007642) | 1.75560908 |
| 148 | Deeply set eye (HP:0000490) | 1.75472813 |
| 149 | IgG deficiency (HP:0004315) | 1.73251526 |
| 150 | Stereotypic behavior (HP:0000733) | 1.72848575 |
| 151 | Intellectual disability, progressive (HP:0006887) | 1.72811268 |
| 152 | Metabolic alkalosis (HP:0200114) | 1.72718087 |
| 153 | Esotropia (HP:0000565) | 1.72696419 |
| 154 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 1.72209425 |
| 155 | Resting tremor (HP:0002322) | 1.70760855 |
| 156 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.70448369 |
| 157 | Dyskinesia (HP:0100660) | 1.70236064 |
| 158 | Intestinal atresia (HP:0011100) | 1.69723336 |
| 159 | Congenital sensorineural hearing impairment (HP:0008527) | 1.69577766 |
| 160 | Decreased circulating renin level (HP:0003351) | 1.69407365 |
| 161 | Recurrent skin infections (HP:0001581) | 1.69073866 |
| 162 | Mask-like facies (HP:0000298) | 1.68783752 |
| 163 | Specific learning disability (HP:0001328) | 1.68016203 |
| 164 | Pulmonary infiltrates (HP:0002113) | 1.66364358 |
| 165 | Renal cortical cysts (HP:0000803) | 1.65850453 |
| 166 | Meningitis (HP:0001287) | 1.65003268 |
| 167 | Termporal pattern (HP:0011008) | 1.64018719 |
| 168 | Insidious onset (HP:0003587) | 1.64018719 |
| 169 | Pulmonary embolism (HP:0002204) | 1.63131471 |
| 170 | Bradycardia (HP:0001662) | 1.62390580 |
| 171 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.60841585 |
| 172 | Abnormality of macular pigmentation (HP:0008002) | 1.60619214 |
| 173 | Genital tract atresia (HP:0001827) | 1.60359668 |
| 174 | Diplopia (HP:0000651) | 1.59906934 |
| 175 | Abnormality of binocular vision (HP:0011514) | 1.59906934 |
| 176 | Central scotoma (HP:0000603) | 1.59835411 |
| 177 | Thickened helices (HP:0000391) | 1.59353541 |
| 178 | Gastroesophageal reflux (HP:0002020) | 1.58453633 |
| 179 | Cerebral inclusion bodies (HP:0100314) | 1.57718839 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 4.47254559 |
| 2 | BRD4 | 4.30299260 |
| 3 | NTRK3 | 4.14682234 |
| 4 | EPHA4 | 3.92355870 |
| 5 | MAP3K4 | 2.99958795 |
| 6 | MAP3K12 | 2.96508825 |
| 7 | TAOK3 | 2.80094529 |
| 8 | MAP2K7 | 2.69032672 |
| 9 | MAP3K13 | 2.67890573 |
| 10 | MAP3K9 | 2.40345716 |
| 11 | MAP2K4 | 2.24671514 |
| 12 | AKT3 | 2.17795834 |
| 13 | GRK5 | 2.14437944 |
| 14 | TXK | 2.07283666 |
| 15 | RIPK4 | 2.06781224 |
| 16 | ACVR1B | 1.98115167 |
| 17 | MINK1 | 1.80673762 |
| 18 | DAPK2 | 1.73763293 |
| 19 | PLK2 | 1.73675419 |
| 20 | TNIK | 1.63987501 |
| 21 | HIPK2 | 1.62140469 |
| 22 | PRPF4B | 1.57169266 |
| 23 | MARK1 | 1.50792806 |
| 24 | FRK | 1.50578169 |
| 25 | SGK2 | 1.44267279 |
| 26 | NTRK1 | 1.41862882 |
| 27 | BLK | 1.30254687 |
| 28 | NTRK2 | 1.29708334 |
| 29 | BMPR1B | 1.28417208 |
| 30 | CCNB1 | 1.27853986 |
| 31 | PNCK | 1.27707765 |
| 32 | MAP4K2 | 1.27418489 |
| 33 | IRAK1 | 1.23196378 |
| 34 | DAPK1 | 1.22826318 |
| 35 | CSK | 1.19492861 |
| 36 | MAPK13 | 1.19014064 |
| 37 | IRAK2 | 1.17683331 |
| 38 | MKNK2 | 1.16999936 |
| 39 | CDK19 | 1.15530204 |
| 40 | SGK494 | 1.14451957 |
| 41 | SGK223 | 1.14451957 |
| 42 | TEC | 1.13752649 |
| 43 | PAK6 | 1.13579345 |
| 44 | OXSR1 | 1.13326474 |
| 45 | BMPR2 | 1.12696844 |
| 46 | ITK | 1.12599740 |
| 47 | KSR1 | 1.12282486 |
| 48 | SYK | 1.11255495 |
| 49 | PAK3 | 1.10333196 |
| 50 | CAMKK2 | 1.08716377 |
| 51 | PRKCG | 1.04536640 |
| 52 | CAMK2A | 1.03651013 |
| 53 | IKBKE | 1.03257882 |
| 54 | IRAK4 | 1.02410000 |
| 55 | MAP4K1 | 1.01995121 |
| 56 | GRK1 | 1.01422369 |
| 57 | CDK5 | 1.00771696 |
| 58 | KSR2 | 1.00120815 |
| 59 | BTK | 0.98949648 |
| 60 | GRK7 | 0.98908568 |
| 61 | YES1 | 0.93888199 |
| 62 | ADRBK2 | 0.93423514 |
| 63 | STK38 | 0.91242400 |
| 64 | SGK3 | 0.90300161 |
| 65 | NUAK1 | 0.88942083 |
| 66 | EPHA3 | 0.84986428 |
| 67 | MAP3K6 | 0.84283802 |
| 68 | ARAF | 0.83756410 |
| 69 | LATS2 | 0.80886217 |
| 70 | ERBB4 | 0.80779331 |
| 71 | HCK | 0.80644905 |
| 72 | FES | 0.79688560 |
| 73 | TNK2 | 0.77778877 |
| 74 | SGK1 | 0.77571802 |
| 75 | LYN | 0.77305237 |
| 76 | MUSK | 0.74242283 |
| 77 | PIK3CA | 0.73608186 |
| 78 | INSRR | 0.73526772 |
| 79 | PIK3CG | 0.73390843 |
| 80 | CAMK2B | 0.73087619 |
| 81 | CAMKK1 | 0.71546407 |
| 82 | JAK2 | 0.69049658 |
| 83 | DYRK1A | 0.68916741 |
| 84 | FGR | 0.68884880 |
| 85 | CAMK2D | 0.67899388 |
| 86 | SIK3 | 0.66787874 |
| 87 | SIK2 | 0.66049967 |
| 88 | PINK1 | 0.65508977 |
| 89 | LCK | 0.64593653 |
| 90 | CAMK1 | 0.63280423 |
| 91 | MARK2 | 0.62426227 |
| 92 | NLK | 0.62422020 |
| 93 | PRKCQ | 0.61992463 |
| 94 | ERBB3 | 0.61755358 |
| 95 | PRKCE | 0.61504172 |
| 96 | KIT | 0.61116316 |
| 97 | STK11 | 0.60055269 |
| 98 | TAOK1 | 0.59524651 |
| 99 | MAP3K7 | 0.58691354 |
| 100 | BRAF | 0.58275550 |
| 101 | MAP2K6 | 0.57899312 |
| 102 | FGFR2 | 0.56272760 |
| 103 | BCR | 0.56055592 |
| 104 | MATK | 0.54541212 |
| 105 | DYRK3 | 0.54431302 |
| 106 | MAPK7 | 0.54230049 |
| 107 | TRIM28 | 0.54209855 |
| 108 | MAP3K2 | 0.54124794 |
| 109 | CDK3 | 0.53709058 |
| 110 | WNK1 | 0.53332360 |
| 111 | NEK9 | 0.52895178 |
| 112 | BCKDK | 0.52630141 |
| 113 | ADRBK1 | 0.52266596 |
| 114 | JAK1 | 0.50084998 |
| 115 | JAK3 | 0.48870361 |
| 116 | GRK6 | 0.48024487 |
| 117 | RAF1 | 0.47115332 |
| 118 | MAPK10 | 0.46499673 |
| 119 | PDK1 | 0.45633161 |
| 120 | IKBKB | 0.45596908 |
| 121 | TLK1 | 0.45532684 |
| 122 | MAP3K14 | 0.43393213 |
| 123 | PDPK1 | 0.42179933 |
| 124 | CDK18 | 0.41839322 |
| 125 | TYRO3 | 0.41644202 |
| 126 | PTK2B | 0.41330802 |
| 127 | CSNK1G2 | 0.41054253 |
| 128 | CAMK1G | 0.40388775 |
| 129 | CAMK4 | 0.40345322 |
| 130 | RPS6KA3 | 0.39621445 |
| 131 | CDK14 | 0.39190174 |
| 132 | WNK3 | 0.38863168 |
| 133 | PKN1 | 0.37627426 |
| 134 | PRKACA | 0.37212563 |
| 135 | CDK9 | 0.37054089 |
| 136 | CAMK2G | 0.36178299 |
| 137 | PDK3 | 0.35792472 |
| 138 | PDK4 | 0.35792472 |
| 139 | MAPK12 | 0.35450636 |
| 140 | CDK15 | 0.35367027 |
| 141 | NME1 | 0.33632025 |
| 142 | PRKCZ | 0.32670362 |
| 143 | MAP3K1 | 0.31512869 |
| 144 | RPS6KB1 | 0.31156226 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.65787104 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.20540190 |
| 3 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.97532160 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.85721110 |
| 5 | Long-term potentiation_Homo sapiens_hsa04720 | 2.74568671 |
| 6 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.68880382 |
| 7 | Olfactory transduction_Homo sapiens_hsa04740 | 2.63402562 |
| 8 | Morphine addiction_Homo sapiens_hsa05032 | 2.59885587 |
| 9 | Circadian entrainment_Homo sapiens_hsa04713 | 2.55008462 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.46362913 |
| 11 | Taste transduction_Homo sapiens_hsa04742 | 2.25244273 |
| 12 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.21294549 |
| 13 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.17807903 |
| 14 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.01613251 |
| 15 | Salivary secretion_Homo sapiens_hsa04970 | 2.00480928 |
| 16 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.00237532 |
| 17 | Long-term depression_Homo sapiens_hsa04730 | 1.94161086 |
| 18 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.93929730 |
| 19 | Insulin secretion_Homo sapiens_hsa04911 | 1.81574921 |
| 20 | Renin secretion_Homo sapiens_hsa04924 | 1.72770896 |
| 21 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.65117415 |
| 22 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.62161318 |
| 23 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.61001229 |
| 24 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.58196893 |
| 25 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.56458342 |
| 26 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.53795022 |
| 27 | Phototransduction_Homo sapiens_hsa04744 | 1.53139054 |
| 28 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.49605330 |
| 29 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.48748343 |
| 30 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.47921232 |
| 31 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.45586946 |
| 32 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.45434222 |
| 33 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.42602768 |
| 34 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.35887896 |
| 35 | Cocaine addiction_Homo sapiens_hsa05030 | 1.33148086 |
| 36 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.31400753 |
| 37 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.30788356 |
| 38 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.25117742 |
| 39 | Leishmaniasis_Homo sapiens_hsa05140 | 1.24936762 |
| 40 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.24933534 |
| 41 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.23991225 |
| 42 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.23487288 |
| 43 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.22351632 |
| 44 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.20810443 |
| 45 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.20001942 |
| 46 | Allograft rejection_Homo sapiens_hsa05330 | 1.17754480 |
| 47 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.14787244 |
| 48 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.11974284 |
| 49 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.11132643 |
| 50 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.11063702 |
| 51 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.09639727 |
| 52 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.07276467 |
| 53 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.07120044 |
| 54 | Measles_Homo sapiens_hsa05162 | 1.06985058 |
| 55 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.05235710 |
| 56 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.04225811 |
| 57 | Tuberculosis_Homo sapiens_hsa05152 | 1.03370479 |
| 58 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.01658033 |
| 59 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.01190306 |
| 60 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.00295032 |
| 61 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.99990161 |
| 62 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.98301301 |
| 63 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.96850007 |
| 64 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.89653565 |
| 65 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.88120327 |
| 66 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.86584591 |
| 67 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.86570319 |
| 68 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.85288199 |
| 69 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.85252033 |
| 70 | Gap junction_Homo sapiens_hsa04540 | 0.84066921 |
| 71 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.82078879 |
| 72 | ABC transporters_Homo sapiens_hsa02010 | 0.80256173 |
| 73 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.78962045 |
| 74 | Glioma_Homo sapiens_hsa05214 | 0.78223128 |
| 75 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.77944875 |
| 76 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.77375201 |
| 77 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.76788165 |
| 78 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.75806348 |
| 79 | Asthma_Homo sapiens_hsa05310 | 0.75397173 |
| 80 | Melanogenesis_Homo sapiens_hsa04916 | 0.74841530 |
| 81 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.73996863 |
| 82 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.73915094 |
| 83 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.72814878 |
| 84 | Malaria_Homo sapiens_hsa05144 | 0.72793449 |
| 85 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.71243370 |
| 86 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.70226245 |
| 87 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.69348502 |
| 88 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.69245149 |
| 89 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.68034288 |
| 90 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.67763765 |
| 91 | Platelet activation_Homo sapiens_hsa04611 | 0.66705952 |
| 92 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.66278070 |
| 93 | Circadian rhythm_Homo sapiens_hsa04710 | 0.66094157 |
| 94 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.64625881 |
| 95 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.64373859 |
| 96 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.64369491 |
| 97 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.64143549 |
| 98 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.63701036 |
| 99 | Legionellosis_Homo sapiens_hsa05134 | 0.62336107 |
| 100 | Axon guidance_Homo sapiens_hsa04360 | 0.61414307 |
| 101 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.61174777 |
| 102 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.61115141 |
| 103 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.60482722 |
| 104 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.60037728 |
| 105 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.59829032 |
| 106 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.58705069 |
| 107 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.58585342 |
| 108 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.56210903 |
| 109 | Alzheimers disease_Homo sapiens_hsa05010 | 0.55908879 |
| 110 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.54557770 |
| 111 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.54338819 |
| 112 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.53667045 |
| 113 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.53072014 |
| 114 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.51654008 |
| 115 | Basal transcription factors_Homo sapiens_hsa03022 | 0.49557944 |
| 116 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.49005855 |
| 117 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.48491632 |
| 118 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.46869817 |
| 119 | Bile secretion_Homo sapiens_hsa04976 | 0.46446323 |
| 120 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.45218147 |
| 121 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.45124201 |
| 122 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.43195765 |
| 123 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.41624059 |
| 124 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.36895606 |
| 125 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.34088194 |
| 126 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.33646934 |
| 127 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.32719399 |
| 128 | Huntingtons disease_Homo sapiens_hsa05016 | 0.29146159 |
| 129 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.28246120 |
| 130 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.26623775 |
| 131 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.26459681 |
| 132 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.26275233 |
| 133 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.25807256 |
| 134 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.25478916 |
| 135 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.24979214 |
| 136 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.24883128 |
| 137 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.24479123 |
| 138 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.23940115 |
| 139 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.23440078 |
| 140 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.22779688 |
| 141 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.19263793 |
| 142 | Melanoma_Homo sapiens_hsa05218 | 0.19174561 |
| 143 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.19127102 |

